‘Ct Market Worth Over $5.3 Billion In 2017’ Says Visiongain Report

17 August 2017
Pharma

Visiongain’s new report Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography indicates that the CT Scan market will see over $5.3bn in revenue in 2017.
The lead analyst of the report said:

“The CT scan market is expected to grow at a healthy CAGR over the study period. Some of the major factors attributing to the growth of the market are increasing incidence and prevalence of various cardiovascular diseases, neurological disorders, various cancers, and orthopaedic diseases.

Advances in digital imaging technology, rising awareness in regards to screening and early diagnosis of cancer and chronic cardiovascular diseases, growing geriatric population, and increasing public awareness are further expected to fuel market growth. Changes in wealth and lifestyle globally, particularly in the BRICS emerging economies, will lead to a rise in the number of patients with a variety of cancers and the increase in the number of people undergoing CT scans for treatment and diagnosis.

All these factors coupled with the safety concerns with the use of CT scanners will see the market grow at a slow but steady pace over the forecast period. However, lack of adequate insurance coverage and demand for refurbished equipment in developing and underdeveloped regions are expected to restraint market growth during the forecast period.”

The 143-page report contains 85 tables, charts and graphs that add visual analysis in order to explain developing trends within the Computed Tomography market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading CT submarkets, segmented by product type, with forecasts for High, medium and low-slice CT scanning devices. The market is also segmented by end-user, with forecasts for Hospitals, Diagnostic Centres and others.

The 143-page report offers market forecasts and analysis for 13 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 7 companies leading the CT field in detail.

The Global Computed Tomography (CT) Scan Market Forecast 2017-2027: Revenue Prospects by Product (High-Slice CT, Medium Slice CT and Low Slice CT), End-use (Hospitals, Diagnostic Centres) and Geography report will be of value to anyone who wants to better understand the Computed Tomography market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the CT Scanning industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever